Tuesday, February 28th, 2023, from 2:00 PM ET to 3:00 PM ET • Co-hosted by AST's Women's Health Community of Practice (WHCOP) and Thoracic and Critical Care Community of Practice (TCC COP)
"Reproductive Health after Thoracic Transplantation: An ISHLT Expert Consensus Statement"
(J Heart Lung Transplant. 2022 Oct 26;S1053-2498(22)02177-5. doi: 10.1016/j.healun.2022.10.009.)
In this article:
With surgical and immunosuppressive advances in thoracic organ transplantation over the past 3 decades and attendant improved long-term outcomes, post-transplant pregnancy is an achievable goal for many lung transplant (LT) and heart transplant (HT) recipients. The keys to successful post-transplant pregnancy are preconception and contraceptive planning, appropriate patient risk assessment with comprehensive risk stratification, and optimization of maternal comorbidities and fetal health through careful monitoring... The purpose of this statement is to summarize the current evidence and provide guidance surrounding preconception counseling, patient risk assessment, and medical management, maternal and fetal outcomes, obstetric management, and pharmacologic considerations.
- Michelle Kittleson, MD, PhD • Smidt Heart Institute, Cedars-Sinai, Los Angeles, CA
- Vicky Gerovasili, MD, PhD, FRCP • Harefield Hospital, Royal Brompton and Harefield Hospitals, Guy’s and St Thomas’ NHS Foundation Trust, Harefield, UK
- Deborah Levine, MD, FAST • Stanford Lung Transplant Program, Stanford University, Stanford, CA
All AST Journal Clubs, and featured AST/AJT Journal Clubs, are free but registration is required to attend live.